MicroVention Announces FDA Clearance For Thrombectomy Device

ALISO VIEJO, Calif., June 12, 2018 /PRNewswire/ — MicroVention, Inc. a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA clearance of a new clinical indication for the SOFIA® Catheter (Soft TOrqueable catheter For Intracranial Access) to include contact aspiration technique for successful revascularization among patients with acute ischemic stroke, secondary to intracranial large […]

InspireMD Reports on Expanded 2 Year Follow-up Results from the PARADIGM Clinical Study Using CGuard EPS

TEL AVIV, ISRAEL, May 30, 2018 (GLOBE NEWSWIRE) —  InspireMD, Inc. (NYSE AMER:NSPR), a leader in embolic prevention systems (EPS),  thrombus management technologies and neurovascular devices, today announced that Professor Piotr Musiałek, from the Department of Cardiac and Vascular Diseases, John Paul II Hospital, Kraków, Poland, presented the expanded 24 month […]

CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke

IRVINE, Calif., May 21, 2018 /PRNewswire/ — CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for EMBOTRAP II Revascularization Device, a next generation stent retriever used to capture and remove life-threatening blood clots from […]

BrainQ Technologies Raises $8.8 Million to Treat Neurodisorders With Artificial Intelligence

JERUSALEM, May 15, 2018 /PRNewswire/ — BrainQ, developing Artificial Intelligence (AI) powered technologies to treat neurodisorders in innovative ways, today announced the completion of a financing round, making the total investment in the Company to date stand at $8.8M. The financing included Qure Ventures,, Norma Investments, IT-Farm, and other strategic angel investors […]

Parker Waichman LLP is Investigating Potential Neurovascular Stent Claims Following Recent FDA Safety Alert

NEW YORK, May 14, 2018 /PRNewswire/ — Parker Waichman LLP is investigating potential personal injury and defective medical device claims related to adverse events associated with the use of Neurovascular Stents for Stent-Assisted Coiling (SAC) for the treatment of unruptured brain aneurysms. The Food and Drug Administration (FDA) has received […]

Brainomix announces the CE Mark certificate for the new e-CTA software

OXFORD, England,  May 11, 2018  / PRNewswire / – e-CTA  pro provides fast automated collateral evaluations that use IA and big data  and are based on CTA analysis Brainomix, a medical imaging software company that uses artificial intelligence (AI) for rapid diagnosis and treatment of stroke victims, has received CE Mark approval for its new e-CTA […]

Cerus Endovascular Promotes Stephen Griffin, PhD, to President

FREMONT, Calif. and OXFORD, England, May 11, 2018 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company engaged in the design and development of highly differentiated and proprietary interventional neuroradiology devices and delivery systems for the treatment of acute, life-threatening neurological conditions, specifically, intracranial aneurysm, today announced the promotion of Stephen Griffin, PhD, […]

New Scientia Vascular Product Facilitates Stroke Treatment

WEST VALLEY CITY, Utah–(BUSINESS WIRE)–Scientia Vascular, an early stage medical device company with patented and proprietary vascular access technology, recently received FDA clearance for a new product called the Aristotle 14 guidewire, which is used during ischemic and hemorrhagic strokes and other challenging interventional procedures. The Aristotle guidewire improves access […]

Stryker’s Trevo™ Retriever becomes first and only device indicated for acute ischemic stroke treatment up to 24 hours in Europe

KALAMAZOO, Michigan, USA, May 7, 2018 /PRNewswire/ — Following the expanded indication in the United States by the Food and Drug Administration (FDA) in February, Stryker’s Trevo Retriever has received CE marking as a front-line treatment for patients experiencing acute ischemic stroke up to 24 hours from symptom onset, increasing the treatment window by 18 […]

iSchemaView Receives FDA Clearance for RAPID CTA Leader in Advanced Cerebrovascular Imaging First to Meet the Needs of Large and Small Centers and Hospitals with New CTA Support and 3D Imaging Added to Complete Suite of RAPID Offerings

Menlo Park, Calif. – May 1, 2018 – iSchemaView, the leader in cerebrovascular imaging analysis, today announced it has received final clearance from the U.S. Food and Drug Administration (FDA) for RAPID CTA, the company’s 3D imaging solution for Computed Tomography Angiography. RAPID CTA is the newest addition to iSchemaView’s industry […]